e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Persistence of the asthmatic response in two animal models with exposure to high and low molecular weight agents
M. Olle-Monge, D. Alvarez-Simón, S. Gómez-Ollés, M. D. Untoria, F. Morell, M. J. Cruz, X. Munoz (Barcelona, Spain)
Source:
Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Session:
Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Session type:
Thematic Poster Session
Number:
4247
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Olle-Monge, D. Alvarez-Simón, S. Gómez-Ollés, M. D. Untoria, F. Morell, M. J. Cruz, X. Munoz (Barcelona, Spain). Persistence of the asthmatic response in two animal models with exposure to high and low molecular weight agents. Eur Respir J 2013; 42: Suppl. 57, 4247
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Occupational asthma induced by exposure to high and low molecular weight agents. Similarities and differences
Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis
Year: 2013
Anti-IgE as an alternative treatment for occupational asthma due to low molecular weight agents
Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Year: 2016
A murine ovalbumin model exhibits molecular features of steroid insensitive human asthma
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
A new naturalistic asthma model in the environmental exposure chamber to study mild asthmatics safely and consistently
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Effects of prenatal tobacco smoke exposure on pulmonary signaling networks in a murine model
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Crucial timing of a viral component exposure to exacerbate allergen-induced asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
T
H
2 specific biomarker profile determines steroid responsiveness in severe asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
The effect of different PV extracts in the treatment of asthma in an animal model
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Differences in association between endotoxin and asthma and wheeze with environmental exposures
Source: International Congress 2015 – Indoor air and ambient pollution
Year: 2015
Effects of chronic cigarette smoke exposure on lung inflammation in ovalbumin-sensitized mice
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Dose-dependent differential effects of thrombin in allergic bronchial asthma
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Environmental tobacco smoke (ETS) induced immunologic changes in children with asthma
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014
Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Standardization of a murine model of asthma due to soybean inhalation
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
Higher prevalence and level of IgE, particularly to furry animals, in subjects with asthma in Sweden
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
B cells in a murine model of allergic asthma and respiratory tolerance
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Obese patients with partially controlled asthma: Weight control shows more benefit in IgE low patients
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Duvelisib, a PI3K-δ,γ inhibitor, in subjects with mild asthma
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept